A Randomized Placebo-Controlled Trial of an Oral Preparation of High Molecular Weight Fucoidan in Patients With Type 2 Diabetes With Evaluation of Taste Sensitivity

Yonago Acta Medica - Japan
doi 10.33160/yam.2019.03.003
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Tottori University Faculty of Medicine

Related search

Effects of Light Therapy on Mood and Insulin Sensitivity in Patients With Type 2 Diabetes and Depression: Results From a Randomized Placebo-Controlled Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2019English

Effect of a Dual PPAR Α/Γ Agonist on Insulin Sensitivity in Patients of Type 2 Diabetes With Hypertriglyceridemia- Randomized Double-Blind Placebo-Controlled Trial

Scientific Reports
Multidisciplinary
2019English

Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2017English

Effect of Linagliptin and Voglibose on Metabolic Profile in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

BMC pharmacology & toxicology
MedicinePharmacology
2018English

Randomized Controlled Trial of a Nationally Available Weight Control Program Tailored for Adults With Type 2 Diabetes

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2016English

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Hydroxychloroquine in Patients With Type 2 Diabetes Mellitus

Global Journal of Endocrinological Metabolism
2018English

The Effect of Probiotic Supplementation on Glycemic Control and Lipid Profile in Patients With Type 2 Diabetes: A Randomized Placebo Controlled Trial

Diabetes and Metabolic Syndrome: Clinical Research and Reviews
Internal MedicineMedicineDiabetesMetabolismEndocrinology
2019English

Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients With Type 2 Diabetes: A Randomized Controlled Trial

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2018English

Dose-Dependent Effects of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes Inadequately Controlled With Metformin: A Randomized, Double-Blind, Placebo-Controlled Trial

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy